MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 26.7

Change

-0.23 (-0.86)%

Market Cap

N/A

Volume

800.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-1.56 (-2.83%)

USD 45.40B
QQQM Invesco NASDAQ 100 ETF

-1.12 (-0.56%)

USD 39.18B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.02 (-0.04%)

USD 22.49B
ACWI iShares MSCI ACWI ETF

-0.24 (-0.20%)

USD 19.99B
CGABL The Carlyle Group Inc. 4.625% ..

-0.02 (-0.12%)

USD 16.14B
SNDK Sandisk Corp

+0.21 (+0.61%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.43B
TSLL Direxion Shares ETF Trust - Di..

-0.51 (-4.82%)

USD 4.44B
NVDL GraniteShares 1.5x Long NVDA D..

-0.41 (-1.07%)

USD 3.04B
IBTF iShares iBonds Dec 2025 Term T..

+0.01 (+0.02%)

USD 2.18B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.18% 75% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.18% 74% C 73% C
Trailing 12 Months  
Capital Gain -6.38% 26% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.38% 24% F 47% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.83% 32% F 40% F
Dividend Return -0.83% 26% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.71% 80% B- 96% N/A
Risk Adjusted Return -22.33% 21% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector